The Greater Birmingham region is located in the very centre of the UK, anchored by Birmingham; a dynamic and ambitious city, the biomedical and medtech community is the rising star in worldwide life science destinations. Perfect for expanding companies in the Life Sciences industry, the region combines extensive research and development facilities, strong collaboration between academia and business as well as one of Europe’s largest, most diverse and non-transient patient populations.
With state-of-the-art clinical facilities, population scale and diversity and pioneering partnerships between academics and clinicians, Greater Birmingham is truly at the cutting edge of medical technology and global healthcare.
The region is going through an unprecedented period of transformation, and is leading post recession national growth and development trends. With record levels of infrastructure investment, increasing international recognition and countless opportunities for companies to thrive in the region, there has never been a better time to invest in Greater Birmingham.
Business Birmingham and Solihull for Success are inward investment agencies working together to attract foreign direct investment and promote development in the area as part of the European Regional Development Fund (ERDF) Investing in Greater Birmingham programme, on behalf of the Greater Birmingham and Solihull Local Enterprise Partnership (GBSLEP).
Life Sciences in the UK
- The strongest bioscience cluster in Europe (Bio-Industry Association).
- The UK is home to four of the world’s top 10 universities for clinical, pre-clinical and health subjects.
- One sixth of the most popular prescription medicines were developed in the UK.
- 17 of the 20 biggest pharmaceutical companies in the world have research and development, manufacturing and sales sites across the UK.
Life Sciences in Greater Birmingham
- The large, ethnically diverse, non-transient, regional population of nearly six million offers the perfect landscape for delivering clinical trials.
- The Institute of Translational Medicine is a world-class clinical research facility in Greater Birmingham. It serves as an engine to translate laboratory discovery into improved and increasingly personalised patient care, with bioinformatics and precision medicine at its core.
- Internationally recognised clinical academic community.
- One of largest clinical trials’ portfolios in Europe, immediate access to both state-of-the-art facilities for experimental medicine and world-leading academic expertise.
- Ready access to Life Sciences infrastructure through Queen Elizabeth Hospital Birmingham (QEHB), one of the largest teaching hospitals in Europe.
- 600 medical technology companies, more than any other UK region.
- Globally, one of the few centres equipped to deliver the full circle of translational medicine The University of Birmingham has the second largest medical school in the country. Universities across the region provide significant numbers of high calibre graduates in medical, biochemistry, engineering and related fields to meet the future needs of investors.
- A high quality IT infrastructure is in place to support Life Sciences activity: the QEHB has a world-class track record in the design, delivery and commercialisation of clinical decision support systems.
- Birmingham Health Partners, a pioneering alliance between academics and clinicians, that aims to translate laboratory discoveries into clinical practice at a pace, scale and efficiency which is unrivalled in the UK.
- BHP provides a framework for unique output and interaction with SMEs in addition to global pharmaceutical and diagnostics companies.
- Home of the largest NIHR Wellcome Trust Clinical Research Facility in the UK (a facility that provides high-quality clinical environments where patients can take part in experimental and complex clinical research studies), a national Biomedical Research Unit in Liver Disease, a centre for Rare Diseases, the largest specialist Cancer Trials Unit in the UK and a national centre for Trauma Research.
- A new £353 million Midland Metropolitan Hospital in Greater Birmingham will deliver a medical and economic boost to the region. Construction work has begun and it is due to open in 2019, serving an area of over half a million people.
Business, Professional and Financial Services (BPFS)